Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04598074 · ClinicalTrials.gov registry record · NA
Opioid Package Prototype (OPP)
A NA study, sponsored by UConn Health.
- Not yet
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT04598074 is a NA study that has not yet begun recruiting, run by UConn Health. The registered enrollment target is 352 participants.
The verdict
NCT04598074, a NA study, has not yet begun recruiting, sponsored by UConn Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
The overall objective of this clinical trial is to identify the impact of selected package features, known as the Opioid Package Prototype (OPP), on the safe and effective use of opioids. Our specific aims are: (Aim 1) to evaluate the effectiveness of OPP on prescribing, dispensing, and patient use of oxycodone among orthopaedic surgery patients receiving post-operative outpatient oxycodone for post-surgical pain management, and (Aim 2) to determine the feasibility of OPP for orthopaedic surgery prescribers, pharmacists, and orthopaedic surgery patients. Such data can be used to further optimize packaging and labeling design, help patients and caregivers utilize their medication and packaging correctly, and improve prescribing and dispensing habits. The central hypothesis is that the OPP will be more effective than the amber vial in efforts to reduce oxycodone prescribing among patients over 18 receiving short-term management of post orthopedic surgery pain.
Interventions
- OTHER Opioid Package Prototype (OPP)
- OTHER Usual Care (standard amber vial)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2025-09-07 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04598074
The ClinicalTrials.gov registry entry for NCT04598074 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Opioid Package Prototype (OPP) is the first listed.
NCT04598074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04598074 about?
NCT04598074 is a clinical study titled "Opioid Package Prototype (OPP)". The overall objective of this clinical trial is to identify the impact of selected package features, known as the Opioid Package Prototype (OPP), on the safe and effective use of opioids. Our specific aims are: (Aim 1) to evaluate the effectiveness of OPP on prescribing, dispensing, and patient use ...
What is the current status of trial NCT04598074?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2025-09-07. Estimated completion is 2026-09-30.
What interventions are being tested in trial NCT04598074?
The interventions under investigation include: Opioid Package Prototype (OPP) (OTHER), Usual Care (standard amber vial) (OTHER).
Who is sponsoring clinical trial NCT04598074?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.